GlassScriptPhysician profile
Darren Keith Freeman
NPI 1326184896
$8,287.93
in general payments reported to CMS, 2019-2025
12 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,331 · 2020: $229 · 2021: $1,933 · 2022: $1,774 · 2023: $353 · 2024: $972 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,749 · Travel and Lodging: $239 · Education: $33.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.56 |
| Travel and Lodging | $238.83 |
| Education | $33.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,336.53 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $1,589.15 | 2019-2024 | Proclaim |
| Spinal Simplicity, LLC | $1,417.34 | 2022 | |
| Medtronic USA, INC. | $1,106.99 | 2019-2020 | |
| Nevro Corp. | $298.98 | 2019-2023 | Senza |
| Curonix LLC | $169.49 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $132.28 | 2025 | Excelsius Gps |
| Relievant Medsystems, INC. | $83.08 | 2023 | Intracept |
| Si-Bone, INC. | $79.26 | 2024 | |
| Medtronic, INC. | $33.08 | 2021-2022 | |
| Dexcom, INC. | $22.17 | 2025 | Dexcom G6 Transmitter |
| Nalu Medical, INC. | $19.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.